Back
Vericel Vs. Arbutus Biopharma Industry Stock Comparison
Buy
58
VCEL
Vericel
Last Price:
48.04
Seasonality Move:
2.13%
Buy
58
ABUS
Arbutus Biopharma
Last Price:
2.89
Seasonality Move:
22.2%
Buy
58
Vericel (VCEL)
is a Buy
Is Vericel a Buy, Sell or Hold?
- The current Vericel [VCEL] share price is $48.10. The Score for VCEL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VCEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Arbutus Biopharma (ABUS)
is a Buy
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $2.88. The Score for ABUS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ABUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCEL Stock Price Chart
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $2.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABUS is experiencing slight buying pressure.
VCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 52.64 | Buy |
| Chaikin Money Flow: | -105238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.58 - 48.98) | Buy |
| Bollinger Bands (100): | (39.25 - 49.33) | Buy |
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 56.66 | Buy |
| Chaikin Money Flow: | 39895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.71 - 2.95) | Buy |
| Bollinger Bands (100): | (2.41 - 2.87) | Buy |
VCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.97 | Buy |
| 20-day SMA: | 46.79 | Buy |
| 50-day SMA: | 47.22 | Buy |
| 200-day SMA: | 39.24 | Buy |
| 8-day EMA: | 47.87 | Buy |
| 20-day EMA: | 47.5 | Buy |
| 50-day EMA: | 46.82 | Buy |
| 200-day EMA: | 40.96 | Buy |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.8 | Buy |
| 20-day SMA: | 2.78 | Buy |
| 50-day SMA: | 2.74 | Buy |
| 200-day SMA: | 2.3 | Buy |
| 8-day EMA: | 2.83 | Buy |
| 20-day EMA: | 2.8 | Buy |
| 50-day EMA: | 2.74 | Buy |
| 200-day EMA: | 2.5 | Buy |
Vericel Earnings Growth & VCEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.26 per share, and an increase next year of $0.40 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.07 per share, and a decrease next year of $0.00 per share.
Vericel Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arbutus Biopharma Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||